A significant breakthrough in cancer investigation is emerging with the use of VHH fragments to re-engage mutated p53. This vital malignant suppressor protein is frequently inactivated in various kinds of tumors, https://esocialmall.com/story7470257/nanobodies-reactivate-p53-a-promising-pathway-for-tumor-treatment